Biswas S, Afrose S, Mita M, Hasan M, Shimu M, Zaman S
JGH Open. 2024; 8(11):e70061.
PMID: 39605899
PMC: 11599877.
DOI: 10.1002/jgh3.70061.
Shahid R, Haider Q, Yadav S, Le D, Ahmed S
Clin Med (Lond). 2024; 25(1):100262.
PMID: 39522614
PMC: 11635657.
DOI: 10.1016/j.clinme.2024.100262.
Kimura N, Hiraki M, Furukawa S, Okuyama K, Kohya N, Sakai M
Mol Clin Oncol. 2024; 21(6):89.
PMID: 39391045
PMC: 11462414.
DOI: 10.3892/mco.2024.2787.
Thongsak N, Chitapanarux T, Chotirosniramit A, Chakrabandhu S, Traisathit P, Nakharutai N
Front Public Health. 2024; 12:1389760.
PMID: 39381772
PMC: 11459313.
DOI: 10.3389/fpubh.2024.1389760.
Topkan E, Senyurek S, Kilic Durankus N, Ozturk D, Selek U
J Pers Med. 2024; 14(7).
PMID: 39064000
PMC: 11278407.
DOI: 10.3390/jpm14070746.
Melanoma risk, tumour stage, and melanoma-specific mortality in individuals with diabetes: a systematic review and meta-analysis.
Tonder J, Bonnelykke-Behrndtz M, Laurberg T, Rossell E, Sollie M
BMC Cancer. 2024; 24(1):812.
PMID: 38972968
PMC: 11229239.
DOI: 10.1186/s12885-024-12598-8.
Network of doctors for multimorbidity and diabetes - the NOMAD intervention: protocol for feasibility trial of multidisciplinary team conferences for people with diabetes and multimorbidity.
Bugge S, Henriksen D, Damkier P, Rahbek M, Schousboe K, Rothmann M
Pilot Feasibility Stud. 2024; 10(1):91.
PMID: 38879561
PMC: 11179232.
DOI: 10.1186/s40814-024-01517-0.
Factors associated with sedentary behavior among community-dwelling breast cancer survivors aged 50 years or older.
Park J, Lee J, Nam H, Kim Y
Sci Rep. 2024; 14(1):2396.
PMID: 38514659
PMC: 10957892.
DOI: 10.1038/s41598-024-51172-x.
Impact of preoperative type 2 diabetes mellitus on the outcomes of patients with gastric cancer following gastrectomy: Analysis of 834 patients using propensity score matching.
Peng D, Xiang Y, Tang K, Qiu Y
Biomed Rep. 2023; 19(6):97.
PMID: 37954633
PMC: 10633813.
DOI: 10.3892/br.2023.1679.
Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer.
Liu X, Li D, Gao W, Zhao W, Jin L, Chen P
Front Genet. 2023; 14:1202849.
PMID: 37876593
PMC: 10593476.
DOI: 10.3389/fgene.2023.1202849.
Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System.
Eaglehouse Y, Darmon S, Gage M, Shriver C, Zhu K
Am J Clin Oncol. 2023; 47(2):64-70.
PMID: 37851358
PMC: 10805355.
DOI: 10.1097/COC.0000000000001057.
Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs.
Sakai N, Kamimura K, Terai S
Pharmaceutics. 2023; 15(9).
PMID: 37765160
PMC: 10536625.
DOI: 10.3390/pharmaceutics15092190.
Impact of a Tripartite Collaboration between Oncologist, Pharmacist and Diabetologist in the Management of Patients with Diabetes Starting Chemotherapy: The ONCODIAB Trial.
Paris J, Legris P, Devaux M, Bost S, Gueneau P, Rossi C
Cancers (Basel). 2023; 15(18).
PMID: 37760514
PMC: 10526306.
DOI: 10.3390/cancers15184544.
Increased risk of cancer and cancer-related mortality in middle-aged Korean women with prediabetes and diabetes: a population-based study.
Tran T, Kim S, Song H, Park B
Epidemiol Health. 2023; 45:e2023080.
PMID: 37654164
PMC: 10867518.
DOI: 10.4178/epih.e2023080.
Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome.
Stan M, Georgescu D, Mirestean C, Badulescu F
Diagnostics (Basel). 2023; 13(16).
PMID: 37627906
PMC: 10453380.
DOI: 10.3390/diagnostics13162647.
Team-Based Approach to Reduce Malignancies in People with Diabetes and Obesity.
Zhu Z, Wong S, Sung J, Lam T
Curr Diab Rep. 2023; 23(10):253-263.
PMID: 37535293
PMC: 10520129.
DOI: 10.1007/s11892-023-01518-y.
Diabetes mellitus and risk of breast cancer: a large-scale, prospective, population-based study.
Xiong F, Wang J, Nierenberg J, Van Blarigan E, Kenfield S, Chan J
Br J Cancer. 2023; 129(4):648-655.
PMID: 37402868
PMC: 10421865.
DOI: 10.1038/s41416-023-02345-4.
Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study.
Wang Q, Santoni G, Lagergren J
JNCI Cancer Spectr. 2023; 7(4).
PMID: 37314979
PMC: 10322653.
DOI: 10.1093/jncics/pkad043.
The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression.
Yan B, Li X, Peng M, Zuo Y, Wang Y, Liu P
Exp Mol Med. 2023; 55(6):1145-1158.
PMID: 37258572
PMC: 10318083.
DOI: 10.1038/s12276-023-00997-z.
On the Role of Glycolysis in Early Tumorigenesis-Permissive and Executioner Effects.
Marcucci F, Rumio C
Cells. 2023; 12(8).
PMID: 37190033
PMC: 10137279.
DOI: 10.3390/cells12081124.